Status:
COMPLETED
Treatment of Postoperative Delirium With Continuous Theta Burst Stimulation
Lead Sponsor:
RenJi Hospital
Conditions:
Postoperative Delirium
Eligibility:
All Genders
60-80 years
Phase:
NA
Brief Summary
To determine whether continuous theta burst stimulation can cure postoperative delirium in senior patients.
Detailed Description
Postoperative delirium(POD), a syndrome characterized by an acute change in attention, awareness and cognition, is one of the most common postoperative complications among elderly patients. Impaired n...
Eligibility Criteria
Inclusion
- Aged between 60 to 80 years;
- Having delirium after elective surgery;
- Being able to complete cognitive assessment and confusion assessment methods (CAM);
- Willing to participate before surgery and being competent to provide informed consent.
Exclusion
- Having brain tumor, stroke, or mental disorders (e.g., depression or dementia);
- Having contraindications of cTBS (e.g., head trauma, history of epilepsy or metal implants in the head or heart);
- Participating in other clinical studies.
Key Trial Info
Start Date :
February 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05239897
Start Date
February 7 2022
End Date
March 15 2023
Last Update
November 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji hospital, School of medicine, Shanghai Jiaotong University
Pudong, Shanghai Municipality, China, 200127